Have you or your loved ones been diagnosed with recurrent acute lymphoblastic leukemia?

You may be eligible to participate in a recurrent acute lymphoblastic leukemia clinical trial.

Have you or your loved ones been diagnosed with recurrent acute lymphoblastic leukemia? You may be eligible to participate in a recurrent acute lymphoblastic leukemia clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Leukemia in Houston TX
NCT02392572 | Phase 1 phase 2 | Interventional

Have you or your loved ones been diagnosed with recurrent acute lymphoblastic leukemia?

You may be eligible to participate in a recurrent acute lymphoblastic leukemia clinical trial.

Have you or your loved ones been diagnosed with recurrent acute lymphoblastic leukemia? You may be eligible to participate in a recurrent acute lymphoblastic leukemia clinical trial.

Recruiting

Male & Female

18 Years +

This study is looking to recruit 120 Participants

This phase I/II trial studies the side effects and best dose of ONC201 and to see how well it works in treating patients with acute leukemia or high-risk myelodysplastic syndrome that has returned after a period of improvement (relapsed) or does not respond to treatment (refractory). ONC201 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.